ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus
25 Oct 2025 //
GLOBENEWSWIRE
ITM’s Ph3 COMPETE Shows Higher ORR for ITM-11 vs Everolimus
18 Oct 2025 //
GLOBENEWSWIRE
Methodist’s Generics Gallium68 Edotreotide Receive Approval in US
10 Oct 2025 //
FDA
ITM Presents Ph3 COMPETE Data On 177Lu-edotreotide In GEP-NETs
08 Oct 2025 //
GLOBENEWSWIRE
ITM Presents Study Design of COMPOSE Phase III Trial with ITM-11
19 Jan 2022 //
BUSINESSWIRE
Eight Medicines win CHMP Nod
18 Oct 2016 //
PHARMATIMES
Eleven medicines leap towards EU approval
19 Sep 2016 //
PHARMATIMES

Market Place
Sourcing Support